EssilorLuxottica SA
(NYSE Euronext - Euronext Paris : ESLOF)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic Plc -2.28%89.840.6%$902.31m
ABTAbbott Laboratories -1.61%74.590.8%$887.44m
TMOThermo Fisher Scientific, Inc. -2.85%275.081.0%$886.57m
ISRGIntuitive Surgical, Inc. -2.21%490.412.4%$706.34m
DHRDanaher Corp. -0.23%138.340.7%$706.33m
BDXBecton, Dickinson & Co. -1.22%216.671.1%$647.07m
SYKStryker Corp. -2.66%158.991.3%$568.43m
BSXBoston Scientific Corp. -2.61%30.601.1%$492.72m
INOInovio Pharmaceuticals, Inc. 16.36%8.326.8%$491.36m
EWEdwards Lifesciences Corp. -0.44%198.571.2%$457.96m
DXCMDexCom, Inc. 5.10%262.968.2%$383.35m
BAXBaxter International, Inc. -0.51%79.761.8%$375.87m
ZBHZimmer Biomet Holdings, Inc. -5.81%94.991.7%$258.94m
ALGNAlign Technology, Inc. -7.62%177.046.4%$254.68m
IDXXIDEXX Laboratories, Inc. 0.60%231.753.8%$236.04m

Company Profile

EssilorLuxottica SA designs, manufactures and sale of ophthalmic lenses and ophthalmic optical instruments. It operates through the foloowing business segments: Lenses & Optical Instruments, Equipment, and Sunglasses and Readers. The Lenses & Optical Instruments business segment engages in the production, finishing, distribution and trading of lens and instruments. The Equipment business segment includes production, distribution and sale of high capacity equipment, such as digital surfacing machines and lens polishing machines, which are used in manufacturing plants and prescription laboratories for finishing operations on semi-finished lenses. The Sunglasses and Readers business segment engages in the production, distribution and sale of both non-prescription sunglasses and non-prescription reading glasses. The company was founded on October 6, 1971 and is headquartered in Charenton-le-Pont, France.